268 related articles for article (PubMed ID: 30588552)
1. Clinical features of hypertrophic pachymeningitis in a center survey.
Cação G; Calejo M; Alves JE; Medeiros PB; Vila-Cha N; Mendonça T; Taipa R; Silva AM; Damásio J
Neurol Sci; 2019 Mar; 40(3):543-551. PubMed ID: 30588552
[TBL] [Abstract][Full Text] [Related]
2. IgG4-related disease and hypertrophic pachymeningitis.
Wallace ZS; Carruthers MN; Khosroshahi A; Carruthers R; Shinagare S; Stemmer-Rachamimov A; Deshpande V; Stone JH
Medicine (Baltimore); 2013 Jul; 92(4):206-216. PubMed ID: 23793110
[TBL] [Abstract][Full Text] [Related]
3. Hypertrophic pachymeningitis due to IgG4-related disease (RD-IgG4). A case report.
Sergio P; Alejandro R; Cristian F
Reumatol Clin (Engl Ed); 2023; 19(6):338-344. PubMed ID: 37179159
[TBL] [Abstract][Full Text] [Related]
4. Immune-Mediated Hypertrophic Pachymeningitis and its Mimickers: Magnetic Resonance Imaging Findings.
Matias TB; Cordeiro RA; Duarte JA; de Jarry VM; Appenzeller S; Villarinho L; Reis F
Acad Radiol; 2023 Nov; 30(11):2696-2706. PubMed ID: 36882352
[TBL] [Abstract][Full Text] [Related]
5. Hypertrophic Pachymeningitis in Chinese Patients: Presentation, Radiological Findings, and Clinical Course.
Bi Z; Shang K; Cao J; Su Z; Bu B; Xu S; Liu C
Biomed Res Int; 2020; 2020():2926419. PubMed ID: 32879880
[TBL] [Abstract][Full Text] [Related]
6. Hypertrophic Pachymeningitis Demonstrated by Whole-Body 67Ga Scintigraphy.
Ishii S; Sugawara S; Yamakuni R; Sekino H; Ito H
Clin Nucl Med; 2022 Feb; 47(2):e149-e151. PubMed ID: 34284475
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic pachymeningitis.
Hahn LD; Fulbright R; Baehring JM
J Neurol Sci; 2016 Aug; 367():278-83. PubMed ID: 27423604
[TBL] [Abstract][Full Text] [Related]
8. Pachymeningitis associated with IgG4-related disease and ANCA positivity: Case report and review of the literature.
Gautier F; Neumann L; Adle-Biassete H; Rubenstein E; Bernat AL; Chimon A; Mouly S; Sène D; Comarmond C
Autoimmun Rev; 2023 Apr; 22(4):103285. PubMed ID: 36738953
[TBL] [Abstract][Full Text] [Related]
9. Focal status epilepticus as a manifestation of idiopathic hypertrophic cranial pachymeningitis.
Navalpotro-Gómez I; Vivanco-Hidalgo RM; Cuadrado-Godia E; Medrano-Martorell S; Alameda-Quitllet F; Villalba-Martínez G; Roquer J
J Neurol Sci; 2016 Aug; 367():232-6. PubMed ID: 27423594
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic hypertrophic pachymeningitis.
Kupersmith MJ; Martin V; Heller G; Shah A; Mitnick HJ
Neurology; 2004 Mar; 62(5):686-94. PubMed ID: 15007115
[TBL] [Abstract][Full Text] [Related]
11. The clinical and imaging features of hypertrophic pachymeningitis: a clinical analysis on 22 patients.
Chen H; Zhang W; Jing J; Raza HK; Zhang Z; Zhu J; Liu Y; Cui G; Hua F; Dong L
Neurol Sci; 2019 Feb; 40(2):269-274. PubMed ID: 30377845
[TBL] [Abstract][Full Text] [Related]
12. [Hypertrophic pachymeningitis secondary to IgG4-related disease: case report and review of the literature].
Rodríguez-Castro E; Fernández-Lebrero A; López-Dequidt IA; Rodríguez-Osorio X; López-González FJ; Suárez-Peñaranda JM; Arias M
Rev Neurol; 2015 Oct; 61(7):308-12. PubMed ID: 26411275
[TBL] [Abstract][Full Text] [Related]
13. [A Case of IgG4-related Hypertrophic Pachymeningitis].
Hayashi K; Somagawa C; Hayashi Y; Iwanaga M
No Shinkei Geka; 2018 Dec; 46(12):1103-1109. PubMed ID: 30572308
[TBL] [Abstract][Full Text] [Related]
14. [Pachymeningitis].
Fain O; Mekinian A
Rev Med Interne; 2017 Sep; 38(9):585-591. PubMed ID: 28413094
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic Pachymeningitis with Characteristics of Both IgG4-related Disorders and Granulomatosis with Polyangiitis.
Mori M; Sakai K; Saito K; Nojima T; Mohri M; Matsubara K; Hayashi S; Yamada M
Intern Med; 2022 Jun; 61(12):1903-1906. PubMed ID: 34803104
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic hypertrophic pachymeningitis: clinical, laboratory and neuroradiologic features in China.
Zhao M; Geng T; Qiao L; Shi J; Xie J; Huang F; Lin X; Wang J; Zuo H
J Clin Neurosci; 2014 Jul; 21(7):1127-32. PubMed ID: 24589555
[TBL] [Abstract][Full Text] [Related]
17. A nationwide survey of hypertrophic pachymeningitis in Japan.
Yonekawa T; Murai H; Utsuki S; Matsushita T; Masaki K; Isobe N; Yamasaki R; Yoshida M; Kusunoki S; Sakata K; Fujii K; Kira J
J Neurol Neurosurg Psychiatry; 2014 Jul; 85(7):732-9. PubMed ID: 24273222
[TBL] [Abstract][Full Text] [Related]
18. IgG4-related hypertrophic pachymeningitis with chronic subdural haematoma.
Lichtblau N; Aliaga-Arias J; Kalaitzoglou D; Bodi I; Ashkan K; Bhangoo R; Vergani F; Joe D; Stanton B; Galloway J; Carlton-Jones L; Lavrador JP
Pract Neurol; 2023 Oct; 23(5):441-445. PubMed ID: 37460210
[TBL] [Abstract][Full Text] [Related]
19. [Inflammatory hypertrophic cranial pachymeningitis].
Masson C; Boukriche Y; Colombani JM
Presse Med; 2001 Mar; 30(9):411-6. PubMed ID: 11285778
[TBL] [Abstract][Full Text] [Related]
20. Imaging features, clinicopathological analysis and diagnostic strategy of IgG4-related hypertrophic pachymeningitis.
Zhao Y; Xu J
Ann Palliat Med; 2020 Sep; 9(5):2551-2558. PubMed ID: 32819129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
